C
Crescent Biopharma, Inc. (CBIO)
NCM – Real vaqt narxi. Valyuta: USD
16.40
-0.29 (-1.74%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
16.43
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
16.40
-0.29 (-1.74%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
16.43
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Crescent Biopharma, Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlarda saraton terapiyasi nomzodlarini tadqiq qiladi va ishlab chiqadi. Uning portfelida CR-001 mavjud bo'lib, u 3-bosqich klinik sinovda, qattiq o'smalarni davolash uchun patentlangan anti-PD-1/anti-VEGF bispesifik antitel; va CR-002 hamda CR-003. Kompaniya onkologik terapevtik vositalarni ishlab chiqish va tijoratlashtirish bo'yicha Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. bilan strategik hamkorlikni yo'lga qo'ygan. Kompaniya ilgari GlycoMimetics, Inc. nomi bilan tanilgan. Kompaniya 2024-yilda tashkil etilgan va Uoltam, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ellie Im M.D. | Chief Medical Officer |
| Dr. Jan Pinkas Ph.D. | Chief Scientific Officer |
| Dr. Jonathan McNeill M.D. | President & COO |
| Dr. Wenjie Cheng Ph.D. | Senior Vice President of Technical Operations |
| Mr. Christopher Doughty | Chief Business Officer |
| Mr. Joshua T. Brumm | CEO & Director |
| Mr. Richard William Scalzo M.B.A. | Chief Financial Officer |
| Mr. Ryan Lynch | Senior VP of Finance, Treasurer & Chief Accounting Officer |
| Ms. Amy Reilly | Chief Communications Officer |
| Ms. Barbara Bispham Hale J.D. | General Counsel & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-30 | POS AM | cbio-sx3sx1flip.htm |
| 2026-07-30 | 10-Q | cbio-20260630.htm |
| 2026-07-15 | 8-K | cbio-20260714.htm |
| 2026-07-14 | 8-K | cbio-20260714.htm |
| 2026-07-01 | S-3 | a2026crescent-sx3.htm |
| 2026-06-22 | 10-Q/A | cbio-20260331.htm |
| 2026-06-03 | 8-K | cbio-20260602.htm |
| 2026-04-29 | 8-K | cbio-20260429.htm |
| 2026-04-29 | 10-Q | cbio-20260331.htm |
| 2026-04-21 | DEFA14A | defa14-2026proxystatementx.htm |